SciELO - Scientific Electronic Library Online

 
vol.133 número9Oxigenación con membrana extracorpórea en pacientes pediátricos: Comunicación de los 3 primeros casos tratadosEl riesgo de malformaciones congénitas y defectos de la programación genómica, en relación con las técnicas de reproducción asistida y la clonación índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

VALDES R, Enrique; NUNEZ U, Tatiana; PEDRAZA S, Daniel  y  MUNOZ S, Hernán. Recurrent impetigo herpetiformis: Successfully managed with ciclosporine. Report of one case. Rev. méd. Chile [online]. 2005, vol.133, n.9, pp. 1070-1074. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872005000900011.

Impetigo Herpetiformis is a high-risk gestational skin disease that represents a risk for both the mother and offspring. Its management is based on multisystemic support and maternal steroid therapy. When these measures are insufficient to control the disease, the association of ciclosporine to the treatment has been proposed. We report a 24 year-old woman with a 16 weeks pregnancy, that presented with Impetigo Herpetiformis. The disease was refractory to the use of steroids, the patient had a metabolic decompensation and a dehydration with electrolyte imbalance. Therefore, treatment with ciclosporine was initiated and a rapid regression of the lesions was observed. Gestation was maintained, with a good perinatal outcome (Rev Méd Chile 2005; 133: 1071-74).

Palabras llave : Adrenal cortex hormones; Cyclosporine; Impetigo.

        · texto en Español     · pdf en Español